Navidea Biopharmaceuticals (NYSE MKT:NAVB) today announced that it has strengthened its management team with the appointments of Thomas J. Klima as Senior Vice President and Chief Commercial Officer and Michael Tomblyn, M.D., M.S. as Executive Medical Director. These highly experienced and skilled additions to the Company’s team are being made to support the continued emphasis on the growth of Lymphoseek® (technetium Tc 99m tilmanocept) injection.
Help employers find you! Check out all the jobs and post your resume.
